In vitro treatment of Enterococcus faecalis with calcium hydroxide impairs phagocytosis by human macrophages

José Burgos Ponce1, Raquel Zanin Midena2, Karen Henriette Pinke1

  • 1a Department of Surgery, Stomatology, Pathology and Radiology, Bauru School of Dentistry , University of São Paulo , Bauru , Brazil.

Abstract

Insights

Alkaline stress hinders the ability of immune cells to engulf Enterococcus faecalis, potentially explaining persistent root canal infections. Nitric oxide production remained unaffected by this stress.

Area of Science:

  • Microbiology
  • Immunology
  • Endodontics

Background:

  • Enterococcus faecalis is a common cause of persistent root canal infections.
  • Monocyte-derived macrophages (MDMs) are crucial immune cells involved in clearing bacterial pathogens.
  • Alkaline conditions, such as those from calcium hydroxide used in root canal treatment, may affect bacterial virulence and host immune responses.

Purpose of the Study:

  • To investigate the impact of alkaline stress on the phagocytic capacity and nitric oxide (NO) production of MDMs against Enterococcus faecalis.
  • To compare the responses of MDMs to root canal strains versus urine isolates of Enterococcus faecalis under alkaline stress.

Main Methods:

  • Enterococcus faecalis strains were subjected to alkaline stress in vitro.
  • MDM-bacteria interactions were assessed using fluorescence microscopy to quantify phagocytosis.
  • Nitric oxide (NO) concentration in cell supernatants was measured.

Main Results:

  • Alkaline stress significantly reduced MDM phagocytosis of most tested E. faecalis strains.
  • One root canal strain (ATCC4083) showed resistance to impaired phagocytosis.
  • Nitric oxide production by MDMs was not significantly altered by alkaline stress.
  • Urine isolates of E. faecalis induced higher NO levels compared to root canal strains.

Conclusions:

  • Alkaline stress may compromise the immune system's ability to clear E. faecalis in root canals by reducing phagocytosis.
  • Impaired bacterial recognition and phagocytosis by MDMs, possibly due to cell wall alterations, could contribute to treatment failure.
  • Root canal strains of E. faecalis elicit distinct immune responses compared to urinary isolates.
  • These findings suggest a mechanism for E. faecalis persistence in alkaline environments within root canal systems.

Related Concept Videos

Phagocytosis00:41

Phagocytosis

Cells pull particles inward and engulf them in spherical vesicles in an energy-requiring process called endocytosis. Phagocytosis (“cellular eating”) is one of three major types of endocytosis. Cells use phagocytosis to take in large objects—such as other cells (or their debris), bacteria, and even viruses.
92.9K
Phagocytosis00:41

Phagocytosis

Cells pull particles inward and engulf them in spherical vesicles in an energy-requiring process called endocytosis. Phagocytosis ("cellular eating") is one of three major types of endocytosis. Cells use phagocytosis to take in large objects, such as other cells (or their debris), bacteria, and even viruses.
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
7.9K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
529
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
460
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
274